Otsuka Pharmaceutical Co., Ltd. and the Japan Kidney Association, a non-profit organization, have concluded a comprehensive agreement to collaborate in Japan on raising the level of disease awareness and medical care for autosomal dominant polycystic kidney disease (ADPKD), a rare and incurable disease of the kidney.

The Japan Kidney Association and Otsuka will utilize their respective strengths and accumulated experience in the field of nephrology in order to advance the contributions possible to patients with ADPKD and their families.

Chronic kidney diseases impair the healthy lifespans of people afflicted with them. Among them, ADPKD, which is a hereditary and intractable disease, calls for earlier diagnosis, prevention of deterioration of the disease, and broader awareness of it among society and the health professions.

More specific information about the collaboration will be communicated at a later date.